Attached files
| file | filename |
|---|---|
| 10-K - 10-K - KEMPHARM, INC | kmph-10k_20151231.htm |
| EX-31.2 - EX-31.2 - KEMPHARM, INC | kmph-ex312_218.htm |
| EX-23.1 - EX-23.1 - KEMPHARM, INC | kmph-ex231_222.htm |
| EX-32.1 - EX-32.1 - KEMPHARM, INC | kmph-ex321_219.htm |
| EX-31.1 - EX-31.1 - KEMPHARM, INC | kmph-ex311_217.htm |
| EX-10.16 - EX-10.16 - KEMPHARM, INC | kmph-ex1016_221.htm |
Exhibit 32.2
CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of KemPharm, Inc., (the “Company”) for the fiscal year ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, R. LaDuane Clifton, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
|
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
March 15, 2016 |
|
/s/ R. LaDuane Clifton |
|
|
|
|
Name: |
R. LaDuane Clifton |
|
|
|
Title: |
Chief Financial Officer (Principal Financial Officer and Principle Accounting Officer) |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, is not being "filed" by the Company as part of the Report or as a separate disclosure document and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.